IDSA President Martin J. Blaser said in the news release, “It’s important to keep in mind that there is no pandemic right now. Even the H5N1 virus that is currently circulating in Asia and Europe primarily causes a disease affecting birds. There have been very few cases of bird-to-human transmission. Most of those who became sick were in very close contact with poultry.” “The threat of a pandemic to the American people is so low right now that it simply doesn’t justify personal stockpiles of antivirals,” said Leonard Mermel, DO, SCM, president of the Society for Healthcare Epidemiology of America (SHEA). “We need this drug to treat sick people who will suffer from human strains of flu this winter.” He made the statement in a joint news release from SHEA and the Infectious Diseases Society of America (IDSA). The statement follows recent reports of people trying to stockpile the antiviral drug for protection in case a flu pandemic erupts. Scores of governments are stockpiling oseltamivir, but supplies are limited and production is slow. Last week the manufacturer, Roche, suspended shipments of the drug to US pharmacies in an effort to prevent hoarding and save supplies for those who will need it for seasonal flu this winter. Oseltamivir and zanamivir (Relenza), called neuraminidase inhibitors, are the only antiviral drugs considered likely to be of some help if the H5N1 avian flu virus leads to a human flu pandemic. Oct 31, 2005 (CIDRAP News) Two major organizations of infectious disease experts today warned the public against hoarding oseltamivir (Tamiflu), saying the threat of an influenza pandemic is not high enough to warrant it. IDSA-SHEA position statement US officials say they currently have a stockpile of about 2.3 million treatment courses of oseltamivir and expect to have about 2 million more by the end of this year. The government’s current goal is to have enough to treat 20 million people, which is less than 10% of the population. The IDSA advocates storing up enough to treat 25% to 40% of the population. “Given the current shortage of antiviral drugs, institutions should not stockpile drug for prophylaxis of health care workers, as this strategy requires much greater drug supplies than early treatment, and could deplete the reserve necessary for treatment on a national level,” the statement adds. In related news, Canadian pharmacies today stopped cross-border sales of oseltamivir to the United States to allay public concern about the potential for shortages, according to a Bloomberg News report. In announcing the move, the Canadian International Pharmacy Association said there is no evidence of a shortage now, the story said. According to the story, Roche Chairman and Chief Executive Franze Humer said he had discussed the idea with Chinese officials. But reports in Chinese newspapers said Roche had not received any formal proposals from Chinese drug companies to produce the drug, the AP reported. See also: In a position statement also issued today, IDSA and SHEA said, “Personal stockpiling would likely lead to inappropriate use and wastage, as well as foster antiviral drug resistance emergence under some circumstances.” The groups suggested that healthcare facilities consider building a rotating stockpile containing about five times as much oseltamivir and zanamivir as they need in an average flu season, since the shelf life of the two drugs is about 5 years. Meanwhile, the South China Morning Post in Hong Kong said Roche has been talking with the Chinese government about the possibility of jointly producing oseltamivir, according to an Associated Press (AP) report today.
SHARE Email Facebook Twitter Economy, Jobs That Pay, Press Release Harrisburg, PA – Governor Tom Wolf today announced seven new project approvals through the Commonwealth Financing Authority (CFA), totaling more than $20.7 million in funding to support business growth in Pennsylvania that will lead to the creation and retention of more than 1,145 jobs.“Projects like those approved today not only propel business development efforts across the state, but they also enhance the quality of life of Pennsylvanians, all while creating and retaining jobs,” said Governor Wolf. “Specifically, through our new Pipeline Investment Program, we are finally able to provide access to low-cost, clean-burning natural gas to unserved areas in Susquehanna County, saving families and businesses thousands each year and giving the area an advantage when attracting new business. Today’s approvals are a win for these regions – and a win for the commonwealth.”At today’s CFA meeting, one project was approved for funding under the Pipeline Investment Program (PIPE), and six projects were approved for funding under the Business in Our Sites (BOS) program:PIPESusquehanna County$442,274 grant to Leatherstocking Gas Company, LLC, for the extension of a gas line to serve the Borough of Montrose and Township of Bridgewater. The project, with a total estimated cost of $884,548, is anticipated to create 100 jobs and retain 80 jobs.BOSBlair CountyMartinsburg Borough was awarded an $81,045 grant and a $143,097 loan to assist in the redevelopment of an abandoned automobile sales building on 1.26 acres in Martinsburg Borough. BOS funds will be used for acquisition, demolition, water and sewer infrastructure, sidewalks, ramps, curbing, parking, engineering, inspections, and administrative costs. The project, with a total estimated cost of $294,142, is anticipated to create 10 jobs and retain 25 jobs.Chester CountyThe Chester County Industrial Development Authority was awarded a $2,153,570 grant and a $3,230,357 loan to assist with the Coatesville Gateway Redevelopment project in the City of Coatesville. BOS funds will be used for acquisition, environmental remediation, demolition, roads, streets, excavation and grading, utilities, landscaping, and engineering. The project, with a total estimated cost of $21,637,305, is anticipated to create 90 jobs.Clarion CountyThe Clarion County Industrial Authority was awarded a $1,033,214 grant and a $4,256,952 loan to assist in the redevelopment of the former Clarion Owens-Illinois Glass Plant located in Clarion Borough. BOS funds will be used for the installation of utilities, site lighting, roads and streets, water and sewer infrastructure, demolition, remediation, excavation and grading, engineering, and legal costs. The project, with a total estimated cost of $39,699,901, is anticipated to create more than 100 jobs.Lackawanna CountyBlakelyRidge, LLC was awarded a $2,918,510 loan for the acquisition of land and the development of the NEPA Wellness Center in Blakely Borough. BOS funds will be used for acquisitions, roads and streets, water and sewer infrastructure, utilities, excavation and grading, professional services, engineering, permitting fees, signage, and landscaping. The project, with a total estimated cost of $3,954,610, is anticipated to create 250 jobs.Lancaster County2221 Noll Drive, LLC was awarded a $2,516,239 loan to assist with Phase 3 of the development of Lime Spring Square, located in East Hempfield Township. BOS funds will be used for water and sewer infrastructure, landscaping, earthwork, storm water management facilities, off-site and on-site transportation improvements, and floodplain restoration. The project, with a total estimated cost of $4,551,056, is anticipated to create 210 jobs.Northampton CountyThe Green Knight Economic Development Corporation was awarded a $1,577,712 grant and a $2,366,572 loan to assist with the development of the Green Knight Industrial Park II located in Wind Gap Borough. BOS funds will be used for the installation of roads and streets, water and sewer infrastructure, utilities, demolition, excavation and grading, and engineering. The project, with a total estimated cost of $4,938,717, is anticipated to create 280 jobs.For more information about CFA and to view a complete list of approved projects, visit dced.pa.gov. May 25, 2017 Governor Wolf Announces $20.7 Million in Approved Funding for Seven Business Development Projects, Supporting More Than 1,100 Jobs